LEONARDI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.925
EU - Europa 751
AS - Asia 709
AF - Africa 8
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 8.405
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.916
SG - Singapore 352
CN - Cina 318
IT - Italia 156
FI - Finlandia 143
DE - Germania 128
UA - Ucraina 78
FR - Francia 69
GB - Regno Unito 69
SE - Svezia 57
VN - Vietnam 16
NL - Olanda 14
RU - Federazione Russa 12
IE - Irlanda 8
IN - India 7
CA - Canada 5
PL - Polonia 5
BR - Brasile 4
EU - Europa 4
MX - Messico 4
HK - Hong Kong 3
ID - Indonesia 3
LT - Lituania 3
PK - Pakistan 3
AU - Australia 2
BE - Belgio 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
GH - Ghana 2
NP - Nepal 2
AR - Argentina 1
AT - Austria 1
BW - Botswana 1
EC - Ecuador 1
HU - Ungheria 1
IR - Iran 1
JP - Giappone 1
KZ - Kazakistan 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 8.405
Salva come PNG Salva come JPEG
Città #
Fairfield 1.119
Woodbridge 702
Houston 529
Chandler 502
Ashburn 440
Ann Arbor 408
Jacksonville 401
Cambridge 399
Seattle 391
Wilmington 380
Santa Clara 310
Singapore 284
Boardman 183
Princeton 182
San Diego 116
Roxbury 91
Beijing 73
Medford 72
Padova 61
Helsinki 59
Des Moines 58
Nanjing 58
Nanchang 22
New York 21
Dong Ket 16
Shenyang 16
Hebei 15
Guangzhou 14
Tianjin 14
London 13
Dallas 11
Jiaxing 11
Jinan 11
Grafing 9
Milan 9
Dublin 8
Redwood City 8
Kilburn 7
Ogden 7
Zhengzhou 7
Norwalk 6
Changsha 5
Falls Church 5
Hounslow 5
Los Angeles 5
Rome 5
Shanghai 5
Tappahannock 5
Verona 5
Munich 4
Nürnberg 4
Vicenza 4
Brunssum 3
Haikou 3
Kharkiv 3
Lodz 3
Naples 3
Ningbo 3
Palembang 3
Palermo 3
Pune 3
San Francisco 3
Acton 2
Alghero 2
Algiers 2
Bari 2
Beauharnois 2
Campolongo Maggiore 2
Coral Gables 2
Farra di Soligo 2
Fontanelle 2
Frankfurt am Main 2
Fuzhou 2
Hangzhou 2
Hermosillo 2
Hong Kong 2
Indiana 2
Kathmandu 2
Klaipėda 2
Kumasi 2
Kunming 2
Lanzhou 2
Lappeenranta 2
Las Vegas 2
Olomouc 2
Recale 2
Redmond 2
San Donà di Piave 2
Siena 2
Sommacampagna 2
São Paulo 2
Yellow Springs 2
Almaty 1
Amsterdam 1
Aprilia 1
Atlanta 1
Birmingham 1
Bologna 1
Borås 1
Bratislava 1
Totale 7.193
Salva come PNG Salva come JPEG
Nome #
Disinfection of ocular cells and tissues by atmospheric-pressure cold plasma 150
Chaperone patterns in vernal keratoconjunctivitis are distinctive of cell and Hsp type, and are modified by inflammatory stimuli 146
Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression 131
Tear histamine and histaminase during the early (EPR) and late (LPR) phases of the allergic reaction and the effects of Lodoxamide. 124
Efficacy and Tolerability of Ketotifen in the Treatment Of Seasonal Allergic Conjunctivitis: Comparison between Ketotifen 0.025% and 0.05% Eye Drops 119
Vernal keratoconjunctivitis-like disease in adults 117
Urokinase Plasminogen Activator, uPa Receptor, and Its Inhibitor in Vernal Keratoconjunctivitis 115
A novel plasma source for sterilization of living tissues 114
Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities 113
Transforming growth factor-β/Smad - signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis. 112
A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study 112
Corneal staining patterns in vernal keratoconjunctivitis: The new VKC-CLEK scoring scale 112
Unusual high exposure to ultraviolet-C radiation 111
Th1- and Th2-type cytokines in chronic ocular allergy 111
Urban eye allergy syndrome: a new clinical entity? 109
Microarray-based IgE detection in tears of patients with vernal keratoconjunctivitis 106
Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans 105
Profile of Lipid and Protein Autacoids in Diabetic Vitreous Correlates With the Progression of Diabetic Retinopathy 104
Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study. 103
Using helium-generated cold plasma to control infection and healing 103
Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis 101
Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. 101
Histamine effects on conjunctival fibroblasts from patients with vernal conjunctivitis. 100
Cornea verticillata in Fabry disease: a comparative study between slit-lamp examination and in vivo corneal confocal microscopy 100
Characterisation of the phenotype and function of monocyte-derived dendritic cells in allergic conjunctiva 98
Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients. 96
Disinfection of ocular cells and tissues by atmospheric-pressure cold plasma 93
Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: A pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies 93
Atmospheric-pressure cold plasma induces transcriptional changes in ex vivo human corneas 92
Managing ocular allergy in the time of COVID-19 92
Is visual function affected in severe ocular allergies? 91
Conjunctival transcriptome analysis reveals the overexpression of multiple pattern recognition receptors in vernal keratoconjunctivitis 90
Emerging drugs for ocular allergy 89
Tailored Approach to the Treatment of Vernal Keratoconjunctivitis 87
Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population. 87
Allergic conjunctivitis: A cross-sectional study 87
Tear eosinophil cationic protein (ECP) in tears of normal subjects and patients affected by vernal keratoconjunctivitis. 86
Effect of ofloxacin and netilmicin on human corneal and conjunctival cells in vitro 86
Histaminase activity in vernal keratoconjunctivitis. 85
Prevalence of vernal keratoconjunctivitis: a rare disease? 84
Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal keratoconjunctivitis. 84
Allergy and allergic mediators in tears 84
Cytokines, growth factors and MMPs in tears of vernal keratoconjunctivitis (VKC) patients 84
Olopatadine: a drug for allergic conjunctivitis targeting the mast cell 83
Anti-inflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model 82
Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. 81
Effects of cyclosporin A on human conjunctival fibroblasts 81
Detection of severe acute respiratory syndrome coronavirus 2 in corneas from asymptomatic donors 79
Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis 78
Corneal confocal microscopy in patients with vernal keratoconjunctivitis 78
Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases 78
Effects of Th2 cytochines on expression of collagen, MMP-1 and TIMP-1 in conjunctival fibroblasts 74
Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis. 74
Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis 74
Vernal keratoconjunctivitis: pathogenesis and treatment 73
Conjunctival allergen provocation test : guidelines for daily practice 73
Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. 72
Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis. 71
Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments 71
Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new penalties-adjusted corneal fluorescein staining score 70
Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in keratoconjunctivitis patients 69
Identification of human tear fluid biomarkers in vernal keratoconjunctivitis using iTRAQ quantitative proteomics 69
Histamine H4 receptors in normal conjunctiva and in vernal keratoconjunctivitis 68
Vernal keratoconjunctivitis: A severe allergic eye disease with remodeling changes 68
Conjunctival transcriptome analysis reveals the overexpression of multiple pattern recognition receptors in vernal keratoconjunctivitis 68
Ocular Surface Expression of SARS-CoV-2 Receptors 66
The regulatory activity of autophagy in conjunctival fibroblasts and its possible role in vernal keratoconjunctivitis 65
Cytokine and chemochine levels in tears and in corneal fibroblast cultures before and after excimer laser treatment 64
Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease 64
Towards a plasma treatment of corneal infections 63
Office-based ocular procedures for the allergist 62
Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked, controlled 2-year study 61
Small fiber peripheral neuropathy in Wilson disease: an in vivo documentation by corneal confocal microscopy. 61
In-vivo diagnostic measurements of ocular inflammation 61
Epidemiology of allergic conjunctivitis: Clinical appearance and treatment patterns in a population-based study 60
Efficacy and comfort of olopatadine vs ketotifen ophthalmic solutions 55
Allergy and the eye 53
Nonsteroidal antiinflammatory drugs after excimer laser photorefractive keratectomy (PRK): A randomized double blind study 53
Growth factors and collagen distribution in vernal keratoconjunctivitis 50
Investigation of the effects of atmospheric pressure cold plasma 50
Clinical patterns of ocular anaphylaxis in guinea pigs passively sensitized with IgG1 antibodies. 50
Trypsin inhibitory capacity in vernal keratoconjunctivitis 49
Twelve-Month Results of Cyclosporine A Cationic Emulsion in a Randomized Study in Patients With Pediatric Vernal Keratoconjunctivitis 49
Corneal Microstructural Changes by Confocal Microscopy in Vernal Keratoconjunctivitis Patients Treated with Topical Cyclosporine 49
Eosinophils and CD4+ cells contribute to MMP production and tissue remodeling in veronal keratoconjunctivitis and other allergic diseases 46
In vitro effects of fluorochinolone and aminoglycoside antibiotics on human keratocytes 46
Ocular Surface Expression of SARS-CoV-2 Receptors 46
Differential expression of matrix metalloproteinases in vernal keratoconjunctivitis, allergic asthma and nasal polyps 45
Characterization of dendritic cell phenotype in allergic conjunctiva: increased expression of Fc epsilon RI, the high-affinity receptor for immunoglobulin E 45
Heat shock proteins levels and expression in chronic obstructive pulmonary disease and vernal keratoconjunctivitis 44
Effects of cold plasma on pathogenic microorganisms, cells and corneal tissues. 44
Low temperature plasma device for the treatment of corneal infections 43
Management of ocular allergy 42
Allergy and Dry Eye Disease 42
Two years specific sublingual immunotherapy with alternaria extracts 41
Management of Vernal Keratoconjunctivitis 39
Allergic conjunctivitis: a cross-sectional study 38
Antiviral response in vernal keratoconjunctivitis may be protective against COVID-19 38
Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry. 37
Metagenomic analysis of the conjunctival bacterial and fungal microbiome in vernal keratoconjunctivitis 37
Totale 7.799
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.421
article - articoli 34.414
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 140
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.975
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020773 0 0 0 0 0 0 129 179 154 156 89 66
2020/20211.426 54 74 29 105 46 113 206 152 257 154 157 79
2021/20221.517 35 165 187 88 73 64 116 160 93 29 162 345
2022/20231.007 250 89 60 100 169 96 1 65 104 9 49 15
2023/2024479 19 73 53 43 23 36 16 18 45 10 73 70
2024/2025976 10 241 139 86 437 63 0 0 0 0 0 0
Totale 8.521